InvestorsHub Logo
Followers 149
Posts 17898
Boards Moderated 0
Alias Born 04/12/2012

Re: None

Tuesday, 03/13/2018 9:35:27 PM

Tuesday, March 13, 2018 9:35:27 PM

Post# of 5873
ImmunoCellular Therapeutics Q4 Loss Narrows Sharply - Stock Up 6% After-Hours
MT NEWSWIRES 2:19 PM ET 3/13/2018

04:19 PM EDT, 03/13/2018 (MT Newswires) -- ImmunoCellular Therapeutics'(IMUC/WS) net loss narrowed sharply to $0.01 per share in Q4 from $1.36 per share a year earlier, helped by the suspension of its late-stage trial of ICT-107.

It had no revenue as it is still developing immune-based therapies for cancer.

Price: 0.3333, Change: +0.02, Percent Change: +5.78

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

©http://www.mtnewswires.com Copyright © 2018 MT Newswires